Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Adding a second method to PROTACs could improve cancer treatment.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Combining FTSC with TSN6 peptide greatly improves wound healing.

Early diagnosis and multidisciplinary care are crucial for managing CNOT3 syndrome.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

New therapy helps treat hair loss.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

TTD hair brittleness is caused by multiple structural abnormalities.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Two siblings were diagnosed with Trichothiodystrophy, identified by brittle hair and low sulfur content.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Wnt signaling controls whether hair follicle stem cells stay inactive or regenerate hair.

A woman with a rare hair loss condition developed skin cancer in the bald area.